Home > News By Company > RNCOS
Technological Advancements to Drive German Pharma Market
The pharmaceutical market in Germany is projected to grow at a CAGR of around 5% during 2010-2012, says a new report from RNCOS.
(EMAILWIRE.COM, April 27, 2010 ) New Delhi, India - Germany is the third largest pharmaceutical market in the world and the largest in Europe. The size of country’s pharmaceutical market is twice that of Italy’s; in per capita terms, it is similar to Austria. The generics acceptance rate in the country is also quite high when compared to the other European countries. According to our research on the sector called “German Pharma Sector Analysis”, the pharma market in Germany is expected to grow at a CAGR of around 4.8% during 2010-2012.
We have done extensive research and prudent analysis of the German pharmaceutical market in order to identify the drivers that will continue to serve as growth savior for the market in the years to come. We have found that there are many research-based small- and mid-sized pharma firms in the country, which are continuously involved in the research and development of new products. This has resulted into the technical innovation in the industry, which is driving the growth of the industry.
Besides this, various other factors having a significant impact on the industry have been thoroughly discussed in the report. The report also discusses and provides useful information about various segments of the pharma industry in the country. Both generics and branded segments of the German pharma industry have been thoroughly studied and analyzed in our report. Besides, the report also highlights latest trends prevailing in the industry.
“German Pharma Sector Analysis” gives a broad research and rational analysis along with reliable statistics of the German pharma industry. The report has thoroughly examined industrial developments and competitive landscape to help clients understand the market structure and its progress. Brief overview of the key market players, including Bayer Schering, Pfizer, Boehringer Ingelheim and others, have also been included in the report. Most importantly, the report gives future outlook for all the important aspects of the industry giving due consideration to the aftereffects of global economic crisis on base drivers, opportunities and challenges before the pharma industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM253.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
We have done extensive research and prudent analysis of the German pharmaceutical market in order to identify the drivers that will continue to serve as growth savior for the market in the years to come. We have found that there are many research-based small- and mid-sized pharma firms in the country, which are continuously involved in the research and development of new products. This has resulted into the technical innovation in the industry, which is driving the growth of the industry.
Besides this, various other factors having a significant impact on the industry have been thoroughly discussed in the report. The report also discusses and provides useful information about various segments of the pharma industry in the country. Both generics and branded segments of the German pharma industry have been thoroughly studied and analyzed in our report. Besides, the report also highlights latest trends prevailing in the industry.
“German Pharma Sector Analysis” gives a broad research and rational analysis along with reliable statistics of the German pharma industry. The report has thoroughly examined industrial developments and competitive landscape to help clients understand the market structure and its progress. Brief overview of the key market players, including Bayer Schering, Pfizer, Boehringer Ingelheim and others, have also been included in the report. Most importantly, the report gives future outlook for all the important aspects of the industry giving due consideration to the aftereffects of global economic crisis on base drivers, opportunities and challenges before the pharma industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM253.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |